Pfizer Inc.
ORAL SOLUTION FORMULATION
Last updated:
Abstract:
The present invention relates to an oral solution formulation or an oral powder for constitution comprising 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H- -pyrido[2,3-d]pyrimidin-7-one, or a lactate or malate salt thereof, and a buffer system comprising lactic acid or malic acid.
Status:
Application
Type:
Utility
Filling date:
3 May 2019
Issue date:
8 Jul 2021